TNNI3 and acute coronary syndrome: We encountered multiple reports investigating different strategies/hs-cTnI assays by various manufacturers in patients enrolled in the Advantageous Predictors of Acute Coronary Syndromes Evaluation (APACE) study during the same enrolment period.